Quick Take
O'Neill Institute
Jeffrey S. Crowley
Op-Ed
Health Affairs
Katie Keith
The No Surprises Act: A Litigation Status Check
Op-Ed
Health Affairs
Andrew J. Twinamatsiko
A Tale Of Three Decisions: Courts Continue To Reject Challenges To Medicare Negotiation
Journal Article
JAMA Health Forum
S. Sean Tu Dongzhe Hong, Reed F. Beall, Massimiliano Russo, Benjamin N. Rome, Aaron S. Kesselheim, Ameet Sarpatwari
Estimating Costs of Market Exclusivity Extensions For 4 Top-Selling Prescription Drugs in the US
Big Ideas in Brief
Jeffrey S. Crowley Kirk Grisham
Big Idea in Brief: Sustaining Momentum and Increasing Access to PrEP in Uncertain Times
Big Ideas
Jeffrey S. Crowley Kirk Grisham
Big Idea: Sustaining Momentum and Increasing Access to PrEP in Uncertain Times
Op-Ed
Health Affairs
S. Sean Tu Aaron S. Kesselheim, William B. Feldman
Combating Pharmaceutical Patent Thickets In The Trump Administration
Op-Ed
Health Affairs
Suhasini Ravi Katie Keith
The Trump Administration’s Deregulatory Agenda: A Six-Month Review
Op-Ed
The Mail & Guardian
Eric A. Friedman Lawrence O. Gostin
G20, endorse a tax on the world’s ultra-rich to feed the world’s starving
Op-Ed
Nature
Lawrence O. Gostin
What success looks like
Op-Ed
European Society of Medicine
Charles Holmes Jirair Ratevosian
With the United States on Pause, What’s the Role of Europe in a Redefined World of Global Health
Op-Ed
The Washington Post
Regina LaBelle Caleb Banta-Green
Letter to the Editor: How to use the opioid settlement
Op-Ed
Brookings
Regina LaBelle David R. Holtgrave
Progress under threat: The future of overdose prevention in the United States
Op-Ed
Health Affairs
Zachary L. Baron Andrew J. Twinamatsiko
Medicare Drug Price Negotiation Program: A Litigation Status Check
Op-Ed
The Regulatory Review
Katie Keith Andrew J. Twinamatsiko
The Price of Preserving Preventive Services Coverage
Journal Article
JAMA
S. Sean Tu Timothy Bonis
Drug Versioning and Legal Accountability—Reply
Journal Article
Journal of General Internal Medicine
S. Sean Tu Doni Bloomfield, Theodore W. Teng, Aaron S. Kesselheim
Prescription Drug Method-of-Use Patent Protection, 1991–2018
Journal Article
Nature Biotechnology
S. Sean Tu Sarah M. E. Gabriele, Matthew J. Martin, Aaron S. Kesselheim
The strength and importance of government-funded patents for approved drugs
Op-Ed
Hastings Center Report
Lawrence O. Gostin Alexandra Finch Peter Lurie
Making America Healthy Again: Remedies for Robert F. Kennedy Jr.’s Campaign against Chronic Disease
Journal Article
The Hastings Center Report
Lawrence O. Gostin Alexandra Finch Peter Lurie
Making America Healthy Again: Remedies for Robert F. Kennedy Jr.’s Campaign against Chronic Disease
Journal Article
Journal of General Internal Medicine
S. Sean Tu Aaron S. Kesselheim, Joseph S. Ross, Ravi Gupta
Revenue, Patents, and New Generic Competition for Prescription Drugs in the USA
Journal Article
Journal of the International AIDS Society
Charles Holmes Anna Grimsrud, Linda Sande
Differentiated service delivery – beyond HIV treatment for integration and other health needs
Op-Ed
The Wire
Kashish Aneja Lawrence O. Gostin Sam Halabi
WHO Pandemic Agreement: An Opportunity to Turn Past Learnings into Future Actions
Op-Ed
The Petrie Flom Center Bill of Health
Kashish Aneja